Interleukin‐1 blockade treatment decreasing cardiovascular risk

BACKGROUND: Interleukin‐1 (IL‐1) played a role in the occurrence and development of atherosclerosis and cardiovascular events. However, the association between IL‐1 blockage treatment and reducing of cardiovascular risk remains poorly defined. HYPOTHESIS: IL‐1 blockage treatment reduce the risk and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zi‐Heng, Zeng, Xun, Nie, Xiao‐Ying, Cheng, Yun‐Jiu, Liu, Jun, Lin, Xiao‐Xiong, Yao, Hao, Ji, Cheng‐Cheng, Chen, Xu‐Miao, Jun, Fan, Wu, Su‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788469/
https://www.ncbi.nlm.nih.gov/pubmed/31415103
http://dx.doi.org/10.1002/clc.23246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788469/
https://www.ncbi.nlm.nih.gov/pubmed/31415103
http://dx.doi.org/10.1002/clc.23246

Ejemplares similares